Skip to main content
MEDIANA Co.,LTD logo

MEDIANA Co.,LTD — Investor Relations & Filings

Ticker · 041920 ISIN · KR7041920000 KO Manufacturing
Filings indexed 199 across all filing types
Latest filing 2019-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 041920

About MEDIANA Co.,LTD

http://www.mediana-global.com/

Mediana Co., Ltd. is a medical device company specializing in the development and manufacturing of equipment for fast and accurate biosignal measurement. The company's core product lines include patient monitoring devices, automated external defibrillators (AEDs), pulse oximeters, and other emergency medical systems. Mediana serves a global market by offering its own branded products and providing Original Design Manufacturing (ODM) services. The company leverages software technology to enhance the functionality and user convenience of its medical solutions.

Recent filings

Filing Released Lang Actions
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Mediana' (주식회사 메디아나) covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Mediana, detailing quarterly financial performance (19.3Q) including revenue, operating profit, and net income. It explicitly states that these are preliminary figures (잠정치) and not audited results. This fits the definition of an Earnings Release (ER), which provides initial highlights of financial results for a specific period. Q3 2019
2019-10-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often filed with the Financial Supervisory Service/DART) to report insider trading or changes in shareholdings by company directors and executives. Based on the provided categories, this corresponds to 'Director's Dealing' (DIRS).
2019-09-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (insiders). This type of filing is specifically used to notify the market of significant changes in shareholding percentages (crossing thresholds), which falls under the 'Major Shareholding Notification' category.
2019-09-06 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 메디아나' covering the period from 2019-01-01 to 2019-06-30. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Korean
기타경영사항(자율공시)(HeartOn A16 국내 식약처 의료기기 제조허가)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) from Mediana regarding the acquisition of a medical device manufacturing license for their product 'HeartOn A16' from the Korean Ministry of Food and Drug Safety. It details the product features and future utilization plans. Since it does not fit into specific categories like financial reports, M&A, or shareholder notifications, it falls under the general regulatory announcement category.
2019-08-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.